4/28/2014 9:03:03 AM
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present at seven events in May. The company’s itinerary includes a number of prominent scientific and investment conferences, culminating in a presentation at the 2014 ASCO Annual Meeting.
Help employers find you! Check out all the jobs and post your resume.
comments powered by